Get started
Author

Harold J. Miller

Observed name: Harold J Miller
OpenAlex ID: A5113419301
Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes
2025 · John B. Buse, Steven E. Kahn, et al. · Diabetes Care · 33
PDF
Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment
2025 · Ralph A. DeFronzo, Vivian Fonseca, et al. · Diabetes Care · 23
PDF
Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study
2026 · Rosario Pivonello, Rosario Pivonello, et al. · The Lancet Diabetes & Endocrinology · 6
PDF
9323 Open-label Results From Grace, A Phase 3 Double-blind, Randomized-withdrawal Study Of The Selective Glucocorticoid Receptor Modulator Relacorilant For The Treatment Of Endogenous Hypercortisolism (Cushing Syndrome)
2024 · Rosario Pivonello, Giorgio Arnaldi, et al. · Journal of the Endocrine Society · 3
Inadequately controlled type 2 diabetes and hypercortisolism: improved glycemia with mifepristone treatment
2025 · Ralph A. DeFronzo, Vivian Fonseca, et al. · 1
Relacorilant Improved Blood Pressure and Maintained Other Cardiometabolic Improvements in Long-term Study in Patients With Endogenous Hypercortisolism (Cushing Syndrome)
2025 · Richard J. Auchus, Aleksandra Gilis-Januszewska, et al. · Metabolism · 1
MON-088 Effects Of Relacorilant On Pituitary Tumor Volume In Patients With Cushing Disease: Results From The Phase 3 Grace Study
2025 · Georgiana A Dobri, Giorgio Arnaldi, et al. · Journal of the Endocrine Society
PDF
High Medication Burden in Individuals With Difficult-to-Control Type 2 Diabetes: Clinical Characteristics From the CATALYST Study
2025 · Ralph A. DeFronzo, John Buse, et al. · American Heart Journal
Inadequately controlled type 2 diabetes and hypercortisolism: improved glycemia with mifepristone treatment
2025 · Ralph A. DeFronzo, Vivian Fonseca, et al.
Prevalence of Hypercortisolism in Patients with Difficult-to-control Type 2 Diabetes: Final Results from CATALYST Part 1
2025 · John B. Buse, Steven E. Kahn, et al. · Metabolism
Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes
2025 · John B Buse, Steven E. Kahn, et al.
Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes
2025 · John B Buse, Steven E. Kahn, et al.
Works count: 14
Citation count: 123
H-index: 5
I10-index: 4
Year
Topic
Type